Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer
Verschraegen, C.F., Czok, S., Muller, C.Y., Boyd, L., Lee, S.J., Rutledge, T., Blank, S., Pothuri, B., Eberhardt, S., Muggia, F.
Published in Annals of oncology (01.12.2012)
Published in Annals of oncology (01.12.2012)
Get full text
Journal Article
Pegylated liposomal doxorubicin with bevacizumab in the treatment of platinum-resistant ovarian cancer: Toxicity profile results
Czok, S, Jewell, A, Shawki, S, Boyd, L, Smith, H, Blank, S, Muller, C, Verschraegen, C, Muggia, F
Published in Gynecologic oncology (01.03.2011)
Published in Gynecologic oncology (01.03.2011)
Get full text
Journal Article
Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer
Verschraegen, C F, Czok, S, Muller, C Y, Boyd, L, Lee, S J, Rutledge, T, Blank, S, Pothuri, B, Eberhardt, S, Muggia, F
Published in Annals of oncology (01.12.2012)
Get full text
Published in Annals of oncology (01.12.2012)
Journal Article
A SET FOR CONTACTLESS TEMPERATURE CONTROL, A METHOD OF GENERATING ELECTROMAGNETIC RADIATION WAVEFRONTS AND THE USE OF THE SET TO GENERATE PROFILES OF TEMPERATURE FIELDS
CZOK MATEUSZ, MALODOBRA-MAZUR MA GORZATA, TOKARSKI MIRON, ROGUSZCZAK HENRYK WALDEMAR
Year of Publication 18.08.2020
Get full text
Year of Publication 18.08.2020
Patent